AE Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

AE Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,474	Closed	-$320K	–	1707
2021 Q1	$320K	Buy	+1,474	New	+$277K	﹤0.01%	1230
2020 Q3	–	Sell	-2,205	Closed	-$271K	–	1411
2020 Q2	$271K	Buy	+2,205	New	+$250K	﹤0.01%	1060
2019 Q3	–	Sell	-4,473	Closed	-$771K	–	1082
2019 Q2	$771K	Buy	4,473 +750	+20%	+$130K	0.02%	473
2019 Q1	$628K	Buy	+3,723	New	+$554K	0.04%	299

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

AE Wealth Management's GWPH Position: Q2 2021 in Review

AE Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,474 shares — an estimated $320K sold.

AE Wealth Management first reported a position in GWPH in Q1 2019 and held it in 4 quarters. The position peaked at $771K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

AE Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
AE Wealth Management sold 1,474 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $320K.
AE Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 4 quarters.
AE Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $771K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on AE Wealth Management's 13F filing for Q2 2021, filed 21 Jul 2021.